Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms.
Chemoradiotherapy
Functional results
Rectal neoplasm
Tailored therapy
Transanal endoscopic microsurgery
Journal
Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
27
05
2020
accepted:
20
12
2020
pubmed:
19
1
2021
medline:
28
4
2021
entrez:
18
1
2021
Statut:
ppublish
Résumé
The aim of this study was to quantify the incidence of short-term postoperative complications and functional disorders at 1 year from transanal endoscopic microsurgery (TEM) for rectal neoplasms, to compare patients treated with TEM alone and with TEM after preoperative chemoradiotherapy (CRT) and to analyse factors influencing postoperative morbidity and functional outcomes. A retrospective study was conducted on all patients treated with TEM for rectal neoplasms at our institution in January 2000-December 2017. Data from a prospectively maintained database were retrospectively analysed. Patients were divided into two groups: adenoma or early rectal cancer (no CRT group) and locally advanced extraperitoneal rectal cancer with major or complete clinical response after preoperative CRT (CRT group). Short-term postoperative mortality and morbidity and the functional results at 1 year were recorded. The two groups were compared, and a statistical analysis of factors influencing postoperative morbidity and functional outcomes was performed. Functional outcome was also evaluated with the low anterior resection syndrome (LARS) score (0-20 no LARS, 21-29 minor LARS and 30-42 major LARS). One hundred and thirteen patients (71 males, 42 females, median age 64 years [range 41-80 years]) were included in the study (46 in the CRT group). The overall postoperative complication rate was 23.0%, lower in the noCRT group (p < 0.001), but only 2.7% were grade ≥ 3. The most frequent complication was suture dehiscence (17.6%), which occurred less frequently in the noCRT group (p < 0.001). At 1 year from TEM, the most frequent symptoms was urgency (11.9%, without significant differences between the CRT group and the noCRT group); the noCRT group experienced a lower rate of soiling than the CRT group (0% vs. 7.7%; p: 0.027). The incidence of LARS was evaluated in 47 patients from May 2012 on and was 21.3% occurring less frequently in the noCRT group (10% vs. 41.2%; p: 0.012). Only 6.4% of the patients evaluated experienced major LARS. In multivariate analysis, preoperative CRT significantly worsened postoperative morbidity and functional outcomes. TEM is a safe procedure associated with only low risk of severe postoperative complications and major LARS. Preoperative CRT seems to increase the rate of postoperative morbidity after TEM and led to worse functional outcomes at 1 year after surgery.
Sections du résumé
BACKGROUND
The aim of this study was to quantify the incidence of short-term postoperative complications and functional disorders at 1 year from transanal endoscopic microsurgery (TEM) for rectal neoplasms, to compare patients treated with TEM alone and with TEM after preoperative chemoradiotherapy (CRT) and to analyse factors influencing postoperative morbidity and functional outcomes.
METHODS
A retrospective study was conducted on all patients treated with TEM for rectal neoplasms at our institution in January 2000-December 2017. Data from a prospectively maintained database were retrospectively analysed. Patients were divided into two groups: adenoma or early rectal cancer (no CRT group) and locally advanced extraperitoneal rectal cancer with major or complete clinical response after preoperative CRT (CRT group). Short-term postoperative mortality and morbidity and the functional results at 1 year were recorded. The two groups were compared, and a statistical analysis of factors influencing postoperative morbidity and functional outcomes was performed. Functional outcome was also evaluated with the low anterior resection syndrome (LARS) score (0-20 no LARS, 21-29 minor LARS and 30-42 major LARS).
RESULTS
One hundred and thirteen patients (71 males, 42 females, median age 64 years [range 41-80 years]) were included in the study (46 in the CRT group). The overall postoperative complication rate was 23.0%, lower in the noCRT group (p < 0.001), but only 2.7% were grade ≥ 3. The most frequent complication was suture dehiscence (17.6%), which occurred less frequently in the noCRT group (p < 0.001). At 1 year from TEM, the most frequent symptoms was urgency (11.9%, without significant differences between the CRT group and the noCRT group); the noCRT group experienced a lower rate of soiling than the CRT group (0% vs. 7.7%; p: 0.027). The incidence of LARS was evaluated in 47 patients from May 2012 on and was 21.3% occurring less frequently in the noCRT group (10% vs. 41.2%; p: 0.012). Only 6.4% of the patients evaluated experienced major LARS. In multivariate analysis, preoperative CRT significantly worsened postoperative morbidity and functional outcomes.
CONCLUSIONS
TEM is a safe procedure associated with only low risk of severe postoperative complications and major LARS. Preoperative CRT seems to increase the rate of postoperative morbidity after TEM and led to worse functional outcomes at 1 year after surgery.
Identifiants
pubmed: 33459969
doi: 10.1007/s10151-020-02394-4
pii: 10.1007/s10151-020-02394-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
319-331Références
Siegel RL, Miller KD, Jemal A (2017) Cancer statistics. Cancer J Clin 67:7–30. https://doi.org/10.3322/caac.21387
doi: 10.3322/caac.21387
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646. https://doi.org/10.1056/NEJMoa010580
doi: 10.1056/NEJMoa010580
pubmed: 11547717
Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740. https://doi.org/10.1056/NEJMoa040694
doi: 10.1056/NEJMoa040694
pubmed: 15496622
pmcid: 15496622
Baral J (2018) Transanal endoscopic microsurgical submucosa dissection in the treatment of rectal adenomas and T1 rectal cancer. Coloproctology 40:364–372. https://doi.org/10.1007/s00053-018-0291-3
doi: 10.1007/s00053-018-0291-3
pubmed: 30416238
pmcid: 6208633
Lu JY, Lin GL, Qiu HZ, Xiao Y, Wu B, Zhou JL (2015) Comparison of transanal endoscopic microsurgery and total mesorectal excision in the treatment of T1 rectal cancer: a meta-analysis. PLoS ONE 10:e0141427. https://doi.org/10.1371/journal.pone.0141427
doi: 10.1371/journal.pone.0141427
pubmed: 26505895
pmcid: 4624726
Buess G (1993) Review: transanal endoscopic microsurgery (TEM). J R Coll Surg Edinb 38:239–245
pubmed: 7693935
De Graaf EJ, Doornebosch PG, Tollenaar RA, Meershoek-Klein Kranenbarg E, de Boer AC, Bekkering FC, van de Velde CJH (2009) Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol 35:1280–1285. https://doi.org/10.1016/j.ejso.2009.05.001
doi: 10.1016/j.ejso.2009.05.001
pubmed: 19487099
Rizzo G, Zaccone G, Magnocavallo M, Mattana C, Pafundi DP, Gambacorta MA, Valentini V, Coco C (2017) Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer. Eur J Surg Oncol 43:1488–1493. https://doi.org/10.1016/j.ejso.2017.05.011
doi: 10.1016/j.ejso.2017.05.011
pubmed: 28583790
Pucciarelli S, De Paoli A, Guerrieri M, La Torre G, Maretto I, De Marchi F, Mantello G, Gambacorta MA, Canzonieri V, Nitti D, Valentini V, Coco C (2013) Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum 56:1349–1356. https://doi.org/10.1097/DCR.0b013e3182a2303e
doi: 10.1097/DCR.0b013e3182a2303e
pubmed: 24201388
pmcid: 24201388
Marks JH, Valsdottir EB, DeNittis A, Yarandi SS, Newman DA, Nweze I, Mohiuddin M, Marks GJ (2009) Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc 23:1081–1087. https://doi.org/10.1007/s00464-009-0326-5
doi: 10.1007/s00464-009-0326-5
pubmed: 19263164
Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Scanavini Neto A, Gama-Rodrigues J (2011) Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum 54:545–551. https://doi.org/10.1007/DCR.0b013e3182083b84
doi: 10.1007/DCR.0b013e3182083b84
pubmed: 21471754
Valsdottir EB, Yarandi SS, Marks JH, Marks GJ (2014) Quality of life and fecal incontinence after transanal endoscopic microsurgery for benign and malignant rectal lesions. Surg Endosc 28:193–202. https://doi.org/10.1007/s00464-013-3155-5
doi: 10.1007/s00464-013-3155-5
pubmed: 24026565
Coco C, Valentini V, Manno A, Mattana C, Verbo A, Cellini N, Gambacorta MA, Covino M, Mantini G, Miccichè F, Pedretti G, Petito L, Rizzo G, Cosimelli M, Impiombato FA, Picciocchi A (2006) Long-term results after Neoadjuvant ra diochemotherapy for locally advanced resectable extraperitoneal rectal cancer. Dis Colon Rectum 49:311–318. https://doi.org/10.1007/s10350-005-0291-6
doi: 10.1007/s10350-005-0291-6
pubmed: 16456636
Gambacorta MA, Valentini V, Coco C, Morganti AG, Smaniotto D, Miccichè F, Mantini G, Barbaro B, Garcia-Vargas JE, Magistrelli P, Picciocchi A, Cellini N (2004) Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: phase I and II studies. Int J Radiat Oncol Biol Phys 60:139–148. https://doi.org/10.1016/j.ijrobp.2004.01.051
doi: 10.1016/j.ijrobp.2004.01.051
pubmed: 15337549
Glynne-Jones R, Sebag-Montefiore D, Maughan TS, Falk SJ, McDonald AC (2006) A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 17:50–56. https://doi.org/10.1093/annonc/mdj031
doi: 10.1093/annonc/mdj031
pubmed: 16284060
Hospers GA, Punt CJ, Tesselaar ME, Cats A, Havenga K, Leer JW, Marijnen CA, Jansen EP, Van Krieken HH, Wiggers T, Van de Velde CJ, Mulder NH (2007) Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group. Ann Surg Oncol 14:2773–2779. https://doi.org/10.1245/s10434-007-9396-6
doi: 10.1245/s10434-007-9396-6
pubmed: 17653805
pmcid: 2039827
Miller AB (1981) Reporting result of cancer treatment. Cancer 47:207–214. https://doi.org/10.1002/1097-0142(19810101)47:1%3c207::aid-cncr2820470134%3e3.0.co;2-6
doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6
pubmed: 7459811
Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME, Mantini G, Morganti AG, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi-Impiombato F, Cosimelli M, Rotman M (2001) Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 51:371–383. https://doi.org/10.1016/s0360-3016(01)01618-2
doi: 10.1016/s0360-3016(01)01618-2
pubmed: 11567811
Buess G, Kipfmüller K, Hack D, Grüssner R, Heintz A, Junginger T (1988) Technique of transanal endoscopic microsurgery. Surg Endosc 2:71–75. https://doi.org/10.1007/bf00704356
doi: 10.1007/bf00704356
pubmed: 3413659
Weiser MR (2018) AJCC 8th edition: colorectal cancer. Ann Surg Oncol 25:1454–1455. https://doi.org/10.1245/s10434-018-6462-1
doi: 10.1245/s10434-018-6462-1
pubmed: 29616422
Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer 73:2680–2686. https://doi.org/10.1002/1097-0142(19940601)73:11%3c2680::aid-cncr2820731105%3e3.0.co;2-c
doi: 10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c
pubmed: 8194005
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 1360123
pmcid: 1360123
Gervaz P, Rotholtz N, Wexner SD, You SY, Saigusa N, Kaplan E, Secic M, Weiss EG, Nogueras JJ, Belin B (2001) Colonic J-pouch function in rectal cancer patients. Impact of adjuvant chemoradiotherapy. Dis Colon Rectum 14:1667–1675. https://doi.org/10.1007/bf02234388
doi: 10.1007/bf02234388
Jorge JMN, Wexner SD (1993) Etiology and management of faecal incontinence. Dis Colon Rectum 36:77–97. https://doi.org/10.1007/bf02050307
doi: 10.1007/bf02050307
pubmed: 8416784
Emmertsen KJ, Lauberg S (2012) Low anterior resection syndrome score. development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 255:922–928. https://doi.org/10.1097/SLA.0b013e31824f1c21
doi: 10.1097/SLA.0b013e31824f1c21
pubmed: 22504191
Cocilovo C, Smith LE, Stahl T, Douglas J (2003) Transanal endoscopic excision of rectal adenomas. Surg Endosc 17:1461–1463. https://doi.org/10.1007/s00464-002-8929-0
doi: 10.1007/s00464-002-8929-0
pubmed: 12739115
Heidary B, Phang TP, Raval MJ, Brown CJ (2014) Transanal endoscopic microsurgery: a review. Can J Surg 57:127–138. https://doi.org/10.1503/cjs.022412
doi: 10.1503/cjs.022412
pubmed: 24666451
pmcid: 3968206
Steele RJ, Hershman MJ, Mortensen NJ, Armitage NC, Scholefield JH (1996) Transanal endoscopic microsurgery—initial experience from three centres in the United Kingdom. Br J Surg 83:207–210
pubmed: 8689164
Clancy C, Burke JP, Albert MR, O’Connell PR, Winter DC (2015) Transanal endoscopic microsurgery versus standard transanal excision for the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum 58:254–261. https://doi.org/10.1097/DCR.0000000000000309
doi: 10.1097/DCR.0000000000000309
pubmed: 25585086
García-Flórez LJ, Otero-Díez JL (2015) Local excision by transanal endoscopic surgery. World J Gastroenterol 21:9286–9296. https://doi.org/10.3748/wjg.v21.i31.9286
doi: 10.3748/wjg.v21.i31.9286
pubmed: 26309355
pmcid: 4541381
Casadesus D (2009) Surgical resection of rectal adenoma: a rapid review. World J Gastroenterol 15:3851–3854. https://doi.org/10.3748/wjg.15.3851
doi: 10.3748/wjg.15.3851
pubmed: 19701964
pmcid: 2731246
Barendse RM, van den Broek FJ, Dekker E, Bemelman WA, de Graaf EJR, Fockens P, Reitsma JB (2011) Systematic review of endoscopic mucosal resection versus transanal endoscopic microsurgery for large rectal adenomas. Endoscopy 43:941–949. https://doi.org/10.1055/s-0030-1256765
doi: 10.1055/s-0030-1256765
pubmed: 21971923
Farhat S, Chaussade S, Ponchon T, Coumaros D, Charachon A, Barrioz T, Koch S, Houcke P, Cellier C, Heresbach D, Lepilliez V, Napoleon B, Bauret P, Coron E, Le Rhun M, Bichard P, Vaillant E, Calazel A, Bensoussan E, Bellon S, Mangialavori L, Robin F, Prat F, SFED ESD study group (2011) Endoscopic submucosal dissection in a European setting. A multi-institutional report of a technique in development. Endoscopy 43:664–670. https://doi.org/10.1055/s-0030-1256413
doi: 10.1055/s-0030-1256413
pubmed: 21623560
Kidane B, Chadi SA, Kanters S, Colquhoun PH, Ott MC (2015) Local resection compared with radical resection in the treatment of T1 N0 M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum 58:122–140. https://doi.org/10.1097/DCR.0000000000000293
doi: 10.1097/DCR.0000000000000293
pubmed: 25489704
Willett CG, Compton CC, Shellito PC, Efird JT (1994) Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer 73:2716–2720. https://doi.org/10.1002/1097-0142(19940601)73:11%3c2716::aid-cncr2820731111%3e3.0.co;2-9
doi: 10.1002/1097-0142(19940601)73:11<2716::aid-cncr2820731111>3.0.co;2-9
pubmed: 8194011
Doornebosch PG, Tollenaar RA, Gosselink MP, Stassen LP, Dijkhuis CM, Schouten WR, van de Velde CJ, de Graaf EJ (2007) Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer. Colorectal Dis 9:553–558. https://doi.org/10.1111/j.1463-1318.2006.01186.x
doi: 10.1111/j.1463-1318.2006.01186.x
pubmed: 17573752
Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR (2002) Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45:200–206. https://doi.org/10.1007/s10350-004-6147-7
doi: 10.1007/s10350-004-6147-7
pubmed: 11852333
Yamamoto S, Watanabe M, Hasegawa H, Baba H, Yoshinare K, Shiraishi J, Kitajima M (2004) The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology 51:998–1000
pubmed: 15239233
Allaix ME, Arezzo A, Giraudo G, Morino M (2012) Transanal endoscopic microsurgery vs. laparoscopic total mesorectal excision for T2N0 rectal cancer. J Gastrointest Surg 16:2280–2287. https://doi.org/10.1007/s11605-012-2046-8
doi: 10.1007/s11605-012-2046-8
pubmed: 23070621
Bhangu A, Ali SM, Cunningham D, Brown G, Tekkis P (2013) Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis 15:156–163. https://doi.org/10.1111/j.1463-1318.2012.03123.x
doi: 10.1111/j.1463-1318.2012.03123.x
pubmed: 23190113
Morino M, Allaix ME, Famiglietti F, Caldart M, Arezzo A (2013) Does peritoneal perforation affect short- and long-term outcomes after transanal endoscopic microsurgery? Surg Endosc 27:181–188. https://doi.org/10.1007/s00464-012-2418-x
doi: 10.1007/s00464-012-2418-x
pubmed: 22717799
Heafner TA, Glasgow SC (2014) A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors. J Gastrointest Oncol 5:345–352. https://doi.org/10.3978/j.issn.2078-6891.2014.066
doi: 10.3978/j.issn.2078-6891.2014.066
pubmed: 25276407
pmcid: 4173049
Sajid MS, Farag S, Leung P, Sains P, Miles WF, Baig MK (2014) Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Colorectal Dis 16:2–14. https://doi.org/10.1111/codi.12474
doi: 10.1111/codi.12474
pubmed: 24330432
Kapiteijn E, Marijnen CA, Nagtegaal ID (2001) Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646. https://doi.org/10.1056/NEJMoa010580
doi: 10.1056/NEJMoa010580
pubmed: 11547717
Coco C, Rizzo G (2012) Can standard surgical procedure reliably be avoided in major responders after radio(chemo) therapy? In: Multidisciplinary management of rectal cancer, Springer-Verlag Berlin Heidelberg, editor
Martin ST, Heneghan HM, Winter DC (2012) Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 99:918–928. https://doi.org/10.1002/bjs.8702
doi: 10.1002/bjs.8702
Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, Campos FG, Kiss DR, Gama-Rodrigues J (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717. https://doi.org/10.1097/01.sla.0000141194.27992.32
doi: 10.1097/01.sla.0000141194.27992.32
pubmed: 15383798
pmcid: 1356472
Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J, Cecconello I (2008) Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71:1181–1188. https://doi.org/10.1016/j.ijrobp.2007.11.035
doi: 10.1016/j.ijrobp.2007.11.035
pubmed: 18234443
Habr-Gama A, Sabbaga J, Gama-Rodrigues J, São Julião GP, Proscurshim I, Bailão Aguilar P, Nadalin W, Perez RO (2013) Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 56:1109–1117. https://doi.org/10.1097/DCR.0b013e3182a25c4e
doi: 10.1097/DCR.0b013e3182a25c4e
pubmed: 24022527
Araujo RO, Valadão M, Borges D, Linhares E, de Jesus JP, Ferreira CG, Victorino AP, Vieira FM, Albagli R (2015) Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study. Eur J Surg Oncol 41:1456–1463. https://doi.org/10.1016/j.ejso.2015.08.156
doi: 10.1016/j.ejso.2015.08.156
pubmed: 26362228
Smith JD, Ruby JA, Goodman KA, Saltz LB, Guillem JG, Weiser MR, Temple LK, Nash GM, Paty PB (2012) Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 256:965–972. https://doi.org/10.1097/SLA.0b013e3182759f1c
doi: 10.1097/SLA.0b013e3182759f1c
pubmed: 23154394
Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP, Wilson MS, Scott N, O’Dwyer ST (2016) Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 17:174–183. https://doi.org/10.1016/S1470-2045(15)00467-2
doi: 10.1016/S1470-2045(15)00467-2
pubmed: 26705854
Smith FM, Wiland H, Mace A, Pai RK, Kalady MF (2014) Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum 57:311–315. https://doi.org/10.1097/DCR.0b013e3182a84eba
doi: 10.1097/DCR.0b013e3182a84eba
pubmed: 24509452
Coco C, Rizzo G, Mattana C, Gambacorta MA, Verbo A, Barbaro B, Vecchio FM, Pafundi DP, Mastromarino MG, Valentini V (2013) Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. Surg Endosc 27:2860–2867. https://doi.org/10.1007/s00464-013-2842-6
doi: 10.1007/s00464-013-2842-6
pubmed: 23404153
Marijnen CA, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, Klein EK, Leer JWH, Cooperative Investigators of the Dutch Colorectal Cancer Group (2002) Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20:817–825. https://doi.org/10.1200/JCO.2002.20.3.817
doi: 10.1200/JCO.2002.20.3.817
pubmed: 11821466
pmcid: 11821466
Horisberger K, Hofheinz RD, Palma P, Volkert AK, Rothenhoefer S, Wenz F, Hochhaus A, Post S, Willeke F (2008) Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? Int J Colorectal Dis 23:257–264. https://doi.org/10.1007/s00384-007-0408-6
doi: 10.1007/s00384-007-0408-6
pubmed: 18071720
Habr-Gama A, Lynn PB, Jorge JM, São Julião GP, Proscurshim I, Gama-Rodrigues J, Fernandez LM, Perez RO (2016) Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation. Dis Colon Rectum 59:264–269. https://doi.org/10.1097/DCR.0000000000000543
doi: 10.1097/DCR.0000000000000543
pubmed: 26953984
Arezzo A, Lo SG, Passera R, Esposito L, Guerrieri M, Ortenzi M, Bujko K, Perez RO, Habr-Gama A, Stipa F, Picchio M, Restivo A, Zorcolo L, Coco C, Rizzo G, Mistrangelo M, Morino M (2019) Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study. Tech Coloproctol 23:831–842. https://doi.org/10.1007/s10151-019-02049-z
doi: 10.1007/s10151-019-02049-z
pubmed: 31388861
Stijns RCH, de Graaf EJR, Punt CJA, Nagtegaal ID, Nuyttens JJME, van Meerten E, Tanis PJ, de Hingh IHJT, van der Schelling GP, Acherman Y, Leijtens JWA, Bremers AJA, Beets GL, Hoff C, Verhoef C, Marijnen CAM, de Wilt JHW, CARTS Study Group (2019) Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study. JAMA Surg 154:47–54. https://doi.org/10.1001/jamasurg.2018.3752
doi: 10.1001/jamasurg.2018.3752
pubmed: 30304338
Birgisson H, Påhlman L, Gunnarsson U, Glimelius B, Swedish Rectal Cancer Trial Group (2005) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23:8697–8705. https://doi.org/10.1200/JCO.2005.02.9017
doi: 10.1200/JCO.2005.02.9017
pubmed: 16314629
Contin P, Kulu Y, Bruckner T, Sturm M, Welsch T, Müller-Stich BP, Huber J, Büchler MW, Ulrich A (2014) Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. Int J Colorectal Dis 29:165–175. https://doi.org/10.1007/s00384-013-1780-z
doi: 10.1007/s00384-013-1780-z
pubmed: 24136155
Qin Q, Huang B, Cao W, Zhou J, Ma T, Zhou Z, Wang J, Wang L (2017) Bowel dysfunction after low anterior resection with neoadjuvant chemoradiotherapy or chemotherapy alone for rectal cancer: a cross-sectional study from China. Dis Colon Rectum 60:697–705. https://doi.org/10.1097/DCR.0000000000000801
doi: 10.1097/DCR.0000000000000801
pubmed: 28594719